46 e-Letters

published between 2010 and 2013

  • Need to further investigate the efficacy of valproic acid therapy in retinal degenerative disorders
    Sujoy Khan

    Dear Editor,

    We have a few concerns on the report by Clemson CM et al on the efficacy of valproic acid (VPA) in 7 patients with retinitis pigmentosa (RP) [1]. Was the time period of 6 months for using VPA the maximum time that was allowed by the institutional review boards? The degree to which the retina was affected by RP was not mentioned in each case (either in the form of photographic evidence or by electro...

    Show More
  • Re:Response to Outcomes of orbital blowout fracture surgery in children and adolescents
    Stephen G J Ng

    Dear Editor, we thank West et al. for their interest in our paper. Firstly, we wish to point out that as stated in our paper's conclusion, we fully endorse early surgery in all cases of paediatric & adolescent blowout fracture. We are committed to educating referrers and colleagues in other specialities to recognize & refer these patients as soon as possible. Secondly, West et al claim that we did not adequatel...

    Show More
  • Is patching appropriate therapy?
    Philip Lempert

    Newsham's recent article on the management of amblyopia is timely but misdirected. Illusions concerning occlusion therapy are repeated with tourettic persistence despite a lack of supporting objective scientific evidence. (Gregson R. Why are we so bad at treating amblyopia. Eye 2002;16:461-2)

    Reports of effective treatment are diminished by the number of subjects who decide to discontinue treatment. Of tho...

    Show More
  • Re:Lack of scientific rationale for use of valproic acid for retinitis pigmentosa
    Shalesh Kaushal

    Authors' Reply to Sandberg et al. letter entitled "Lack of scientific rationale for use of valproic acid for retinitis pigmentosa"

    Radouil Tzekov 1, Carol Bigelow2, Christine Clemson1, Jenna Checchi1, Mark Krebs3, Shalesh Kaushal1

    Author Affiliations

    1 Department of Ophthalmology University of Massachusetts Medical School Worcester, MA, USA

    2 Division of Biostatistics and Epidemiology/D...

    Show More
  • Lack of scientific rationale for use of valproic acid for retinitis pigmentosa
    Michael A. Sandberg

    Lack of Scientific Rationale for Use of Valproic Acid for Retinitis Pigmentosa

    Michael A. Sandberg, Ph.D., Bernard Rosner, Ph.D., Carol Weigel- DiFranco, Eliot L. Berson, M.D.

    Corresponding author: Michael A. Sandberg, Ph.D. Berman-Gund Laboratory, Harvard Medical School 243 Charles Street Boston, Massachusetts 02114 USA Email: Michael_sandberg@meei.harvard.edu Telephone: 617-573-3605 FAX: 617-573-3216...

    Show More
  • Registration for people with sight impairment - a valued system
    Catey Bunce

    Ryan and Margrain's letter highlights some key findings from a report they conducted on behalf of the Thomas Pocklington Trust. 1 They found that there are many people in Wales requiring visual rehabilitation who do not meet the current criteria for certification as visually impaired. They found also that there had been poor uptake in Wales of systems which were designed to support those who need aid who do not meet such...

    Show More
  • Author's response
    Hannah E Bartlett

    As a research group with no commercial interest in any macular pigment optical density (MPOD) measurement devices, or nutritional supplements, we feel that we were well-placed to carry out this independent clinical assessment of the reliability of MPS 9000. Our study was prompted by the fact that we could find no reported coefficient of repeatability value within the literature, and none was provided by the manufacturer...

    Show More
  • M. tuberculosis in donor corneal tissue
    Soumyava Basu
    Dear editor, I read with interest Catederal et alâ₉„¢s study on the use of polymerase chain reaction (PCR) for detection of Mycobacterium tuberculosis in donor corneal tissues.1 The authors report the presence of M. tuberculosis DNA in donor corneas of patients with no documented history of tuberculosis. However there are several methodological erro...
    Show More
  • Re:Conclusions of Clemson et al. concerning Valproic Acid are premature
    Shalesh Kaushal

    Dear Editor,

    We appreciate the interest of Van Schooneveld et al.1 in our recent BJO article.2 Our small, retrospective chart review of RP patients treated off-label with valproic acid is only the first step in the process of understanding the potential utility of the drug for patients with this sight-threatening condition, for which there are no current therapeutic options.

    The size and the scope of...

    Show More
  • Conclusions of Clemson et al. concerning Valproic Acid are premature
    Mary J. van Schooneveld

    Dear Sir, With great interest we read the article of Clemson et al. about a new treatment for retinitis pigmentosa (RP). However, the authors' claim that their data suggest that valproic acid (VPA) may be an effective treatment for RP is unfounded and also regrettably misleading for the many desperate RP-patients. In fact, we are surprised that the editors of the BJO have published this study in its present form. Firstly,...

    Show More